Diwa, Habil C.

HRN: 15-52-39  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/07/2022
CEFUROXIME 750MG (VIAL)
11/07/2022
11/13/2022
IV
750mg
Q12
Multiple Soft Tissue Injuries
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: